A Wyoming company said Friday it will replace a pipeline that spilled almost 40,000 gallons of oil into a river in Montana with a new line buried more deeply to protect against future accidents. The Jan. 17 spill into the Yellowstone River contaminated the water supply for 6,000 residents of Glendive in eastern Montana.
Training of first responders on the hazards of actual radiological and nuclear threats has been...
The Obama administration said Wednesday it will issue the first regulations to cut down on...
Plans for the construction of the world's largest digital camera at the SLAC National...
In the midst of a worrisome flu season, health officials are pushing doctors to prescribe antiviral medicines. The Centers for Disease Control and Prevention on Friday sent a new alert to doctors, advising prompt use of Tamiflu and other antivirals for hospitalized flu patients and those at higher risk for complications like pneumonia.
New York City will move to the forefront of a growing environmental trend by banning food establishments from using plastic foam containers starting this summer, Mayor Bill de Blasio's administration announced. De Blasio's mayoral ban will fulfill an initiative begun by his predecessor, Michael Bloomberg, who first suggested banning the material in his final State of the City address, in 2013.
Argonne National Laboratory will work with three of the world's leading nuclear products and services companies on projects that could unlock the potential of advanced nuclear reactor designs, helping create a new generation of safer, more efficient reactors.
The Federal Aviation Administration has issued permits to use drones to monitor crops and photograph properties for sale, marking the first time permission has been granted to companies involved in agriculture and real estate. The exemptions to the current ban on commercial drone flights were granted to Advanced Aviation Solutions in Star, Idaho, for “crop scouting,” and to Douglas Trudeau of Tierra Antigua Realty in Tucson, Arizona.
The flu is now widespread in all but seven states, and hospitalization rates match the dismal season two years ago. While health officials fear this will be an unusually bad year, it's too soon to say. The latest figures released Monday by the CDC show the flu hitting hard in most of the 43 states where the illness was widespread. But the flu was not yet rampant in populous states like California and New York.
The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years. FDA drug approvals are considered a barometer of industry innovation and the federal government's efficiency in reviewing new therapies. Last year's total was the most since the all-time high of 53 drugs approved in 1996.
Every year, in conjunction with the R&D 100 Awards Banquet, R&D Magazine’s editors convene a panel of R&D leaders to discuss the current issues confronting their organization’s R&D programs, staff and administration. This year’s panel was held on November 7, 2014, at the Bellagio, Las Vegas, Nev., and included three R&D managers from industry and one each from government and academic organizations.
Sandia National Laboratories is tackling one of the biggest barriers to the use of robots in emergency response: energy efficiency. Through a project supported by DARPA, Sandia is developing technology that will dramatically improve the endurance of legged robots, helping them operate for long periods while performing the types of locomotion most relevant to disaster response scenarios.
Earlier this month, the NTSB released its Aircraft Incident Report on a fire aboard a Japan Airlines Boeing 787, concluding that the fire was probably caused by an internal short circuit within a cell of the lithium-ion battery.
During the 2014 R&D 100 Awards event, R&D Magazine expanded the banquet to hold four technology panels during the day. The last panel of the day focused on energy/environmental solutions and the innovation behind four R&D 100-winning technologies and the complexity of bringing such technologies to the market.
Sandia National Laboratories is studying how environments, including radiation that originates from a nuclear weapon itself, could affect the performance of electronics in the W76-1 warhead as they age. Sandia is helping replace W76 warheads in the U.S. stockpile with a refurbished version under the W76-1 Life Extension Program (LEP). The ballistic missile warhead is carried on the Trident II D5 missile aboard Ohio-class Navy submarines.
The White House says the Obama administration is making strides in the fight against Ebola, citing an expanded hospital network and testing capacity at home and gains confronting the deadly disease in West Africa. To sustain that, President Barack Obama was prodding Congress Tuesday to approve his request for $6.2 billion in emergency spending against the outbreak.
Lawrence Livermore National Laboratory and the RAND Corporation will collaborate to expand the use of high-performance computing in decision analysis and policymaking. The two organizations signed a memorandum of understanding on Friday, Nov. 21. The arrangement provides a vehicle for the two organizations to explore the use of policy analysis methodologies with supercomputing applications.
The next Ebola or the next SARS. Maybe even the next HIV. Even before the Ebola epidemic in West Africa is brought under control, public health officials are girding for the next health disaster. Ebola sprang from one of those blind spots, in an area that lacks the health systems needed to detect an outbreak before it becomes a crisis.
U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking such safeguards. The FDA approved Purdue Pharma's Hysingla ER for patients with severe, round-the-clock pain that cannot be managed with other treatments.
Mark Hart, a scientist and engineer at Lawrence Livermore National Laboratory, has been awarded the 2015 Surety Transformation Initiative (STI) Award from the National Nuclear Security Administration’s Enhanced Surety Program. The STI award aims to stimulate and encourage the development of potentially transformational nuclear weapon surety technologies and explore innovative, preferably monumental shift solutions, to unmet surety needs.
Argonne National Laboratory has announced a new intellectual property licensing agreement with AKHAN Semiconductor, continuing a productive public-private partnership that will bring diamond-based semiconductor technologies to market. The agreement gives AKHAN exclusive rights to a suite of breakthrough diamond-based semiconductor inventions developed by nanoscientist Ani Sumant of Argonne’s Center for Nanoscale Materials.
The government proposed new rules Wednesday to make it easier for doctors and patients to learn if clinical trials of treatments worked or not. Thousands of Americans participate in clinical trials every year, testing new treatments, comparing old ones or helping to uncover general knowledge about health. Many of the studies are reported in scientific journals and trumpeted in the news.
The world still isn't close to preventing what leaders call a dangerous level of man-made warming, a new United Nations report says. That's despite some nations' recent pledges to cut back on carbon dioxide emissions. The report looks at the gap between what countries promise to do about carbon pollution and what scientists say needs to be done to prevent temperatures rising another two degrees.
Millions of people with stents that prop open clogged heart arteries may need anti-clotting drugs much longer than the one year doctors recommend now. A large study found that continuing for another 18 months lowers the risk of heart attacks, clots and other problems. Even quitting after 30 months made a heart attack more likely, raising a question of when it's ever safe to stop.
Nanomedicine is offering patients a growing arsenal of therapeutic drugs for a variety of diseases, but often at a cost of thousands of dollars a month. Generics could substantially reduce the price tag for patients—if only there were a well-defined way to make and regulate them. An article in Chemical & Engineering News (C&EN) details the challenges on the road to generic nanodrugs.
Squeezed R&D budgets in the EU, Japan and U.S. are reducing the weight of advanced economies in science and technology research, patent applications and scientific publications and leaving China on track to be the world’s top R&D spender by around 2019, according to a OECD report.
Health workers on the front line of the Ebola crisis say the need for urgent help isn't letting up, as Congress begins considering President Barack Obama's $6.2 billion emergency aid request to fight the disease. Despite reports that the number of infections is slowing in some parts of West Africa, cases still are rising in other areas.
Medicare may soon begin paying for yearly scans to detect lung cancer in certain current or former heavy smokers. The Centers for Medicare and Medicaid Services on Monday issued a long-awaited proposal to begin covering the screening for high-risk beneficiaries if their doctors agree they meet the criteria.
Dr. Robert Fuller didn't hesitate to go to Indonesia to treat survivors of the 2004 tsunami, to Haiti to help after the 2010 earthquake or to the Philippines after a devastating typhoon last year. But he's given up on going to West Africa to care for Ebola patients this winter. He could make the six-week commitment sought by his go-to aid organization, International Medical Corps.
- Page 1